Toxicity of copper(I)-NHC complexes against human tumor cells: induction of cell cycle arrest, apoptosis, and DNA cleavage

Although NHC-complexes are renowned for their catalytic properties, studies of their anti-cancer properties are scarce. In our search for new potent metal-based drugs, we envisioned that copper(I)-NHC could serve as a stable analogue of copper(I)-phenantroline. Herein, we report the results of the biological evaluation of the anticancer properties of [(SIMes)CuCl] 5. This complex showed impressive cytotoxicity against a panel of human tumor cell lines. Regarding IC50, up to 150 fold decrease is observed compared to cisplatin. Cellular effects of [(SIMes)CuCl] were evaluated at the cell cycle and the apoptotic levels. 5 causes cell cycle arrest at the G1 phase as demonstrated by the concomitant accumulation of protein p21 and the strong down-regulation of cyclin D1. Monitoring of poly-(ADP-ribose)-polymerase, implied in apoptosis response of cells, showed that [(SIMes)CuCl] induces apoptosis at low concentration. Finally, we showed that [(SIMes)CuCl] targets DNA by in vitro studies. When inducing aerobic DNA cleavage, [(SIMes)CuCl] behaves analogously to copper(I)-phenantroline. Thus, our experiments evidenced that employing NHC to deliver active copper(I) species in cellulo is a valuable strategy in anticancer research.